Can herbs and viruses beat Drug-Resistant pneumonia?

NCT ID NCT07338123

Not yet recruiting Disease control Sponsor: Chinese PLA General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase trial tests a Chinese herbal formula (Yiqi Huoxue Jiedu) combined with bacteriophages—viruses that target specific bacteria—in 240 people with severe pneumonia caused by drug-resistant germs. The goal is to see if the combination clears the infection faster and lowers death rates. Because it's a very early study, results are uncertain and mainly check safety and basic effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Yiqi Huoxue Jiedu formula (herbal) and bacteriophages (viruses that kill bacteria)
What this could lead to: If it works, this could point toward a new treatment for severe pneumonia caused by drug-resistant bacteria, potentially reducing death rates.
What could go wrong: This is a very early (Phase 1) trial, so it may not show clear benefits. The combination of herbal medicine and phages is experimental, and risks are not yet well understood.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumonia pneumonia caused by gram negative bacteria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PNEUMONIA

More trials for these conditions

Other studies related to the condition(s) this trial covers.